Motilal Oswal Financial Services has initiated coverage on Molbio Diagnostics with a 'buy' rating and a target price of Rs 1,800, implying a 19 to 21 percent upside from recent closing prices,…
Molbio Diagnostics debuted on the stock market on Monday with shares listing at ₹980 on both the BSE and NSE, a premium of 21.4 per cent over the issue price of ₹807.…
Molbio Diagnostics shares will debut on the NSE and BSE on Monday, 17 August, after its initial public offering saw strong subscription of over 70 times. Grey market sources indicate a listing…
Molbio Diagnostics' Rs 940 crore IPO was subscribed 70.26 times, with the QIB portion oversubscribed 186 times. Allotment is finalised on Thursday, August 13, and refunds begin Friday. Shares list on BSE…
The Rs 939.70 crore initial public offering of Molbio Diagnostics entered its second day of bidding on August 11. The issue, which opened on August 10 and closes on August 12, has…
Molbio Diagnostics' IPO opens today at Rs 768-807 per share to raise up to Rs 940 crore. The company makes the Truenat portable diagnostic platform, endorsed by WHO for tuberculosis testing and…
Three mainboard initial public offerings, from Milky Mist Dairy Food, Dhoot Transmission, and Molbio Diagnostics, will open for subscription this week. An SME offering from Fascinate Textile is also set to open,…
Goa-based Molbio Diagnostics will open its initial public offering on August 10 with a price band of Rs 768 to Rs 807 per share. The issue closes on August 12. The IPO…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.